Kabra Drugs Ltd — Important, 06-01-2026: Company Update

Kabra Drugs Limited confirmed the submission of a compliance certificate from its Registrar and Share Transfer Agent (RTA) for the quarter ended December 31, 2025. This ensures the company's processes for managing share transfers and dematerialization requests are in order. Such routine compliance is key for maintaining accurate shareholder records and operational transparency, providing assurance to investors about the company's administrative diligence.